1. Kofflard MJ, Ten Cate FJ, van der Lee C, van Domburg RT. Hypertrophic cardiomyopathy in a large community-based population: clinical outcome and identification of risk factors for sudden cardiac death and clinical deterioration. J Am Coll Cardiol. 2003; 41:987–993.
Article
2. American College of Cardiology Foundation/American Heart Association Task Force on Practice; American Association for Thoracic Surgery; American Society of Echocardiography; American Society of Nuclear Cardiology; Heart Failure Society of America; Heart Rhythm Society; Society for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons, Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS, Naidu SS, Nishimura RA, Ommen SR, Rakowski H, Seidman CE, Towbin JA, Udelson JE, Yancy CW. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg. 2011; 142:e153–e203.
3. Elliott PM, Poloniecki J, Dickie S, Sharma S, Monserrat L, Varnava A, Mahon NG, McKenna WJ. Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. J Am Coll Cardiol. 2000; 36:2212–2218.
Article
4. Maron BJ, Bonow RO, Cannon RO 3rd, Leon MB, Epstein SE. Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (2). N Engl J Med. 1987; 316:844–852.
5. McKenna W, Deanfield J, Faruqui A, England D, Oakley C, Goodwin J. Prognosis in hypertrophic cardiomyopathy: role of age and clinical, electrocardiographic and hemodynamic features. Am J Cardiol. 1981; 47:532–538.
Article
6. McKenna WJ, Franklin RC, Nihoyannopoulos P, Robinson KC, Deanfield JE. Arrhythmia and prognosis in infants, children and adolescents with hypertrophic cardiomyopathy. J Am Coll Cardiol. 1988; 11:147–153.
Article
7. Olivotto I, Cecchi F, Casey SA, Dolara A, Traverse JH, Maron BJ. Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy. Circulation. 2001; 104:2517–2524.
Article
8. Robinson K, Frenneaux MP, Stockins B, Karatasakis G, Poloniecki JD, McKenna WJ. Atrial fibrillation in hypertrophic cardiomyopathy: a longitudinal study. J Am Coll Cardiol. 1990; 15:1279–1285.
9. Nienaber CA, Hiller S, Spielmann RP, Geiger M, Kuck KH. Syncope in hypertrophic cardiomyopathy: multivariate analysis of prognostic determinants. J Am Coll Cardiol. 1990; 15:948–955.
Article
10. Spirito P, Bellone P, Harris KM, Bernabo P, Bruzzi P, Maron BJ. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med. 2000; 342:1778–1785.
Article
11. Williams L, Frenneaux M. Syncope in hypertrophic cardiomyopathy: mechanisms and consequences for treatment. Europace. 2007; 9:817–822.
Article
12. Rosen KL, Cameron RW, Bigham PJ, Neish SR. Hypertrophic cardiomyopathy presenting with 3rd-degree atrioventricular block. Tex Heart Inst J. 1997; 24:372–375.
13. Przybojewski JZ, van der, Ellis GC, Tiedt FA. Hypertrophic cardiomyopathy complicated by complete heart block. Case report and review of the literature. S Afr Med J. 1984; 66:847–855.
14. Thongtang V, Panchavinin P, Chaithiraphan S. Familial hypertrophic cardiomyopathy associated with spontaneous complete heart block. J Med Assoc Thai. 1991; 74:301–305.
15. Tamura M, Harada K, Ito T, Enoki M, Takada G. Abrupt aggravation of atrioventricular block and syncope in hypertrophic cardiomyopathy. Arch Dis Child. 1995; 73:536–537.
Article
16. Desai DM, Bhat GS, Daxini BV, Sharma S. Complete heart block as a cause of syncope in hypertrophic cardiomyopathy. J Assoc Physicians India. 1991; 39:965–966.